| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Department of Veterans Affairs |
| Information provided by: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00108589 |
Purpose
The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will be accomplished by development of a database of these patients, all of whom will have biopsy documented NASH. A placebo controlled trial will then examine the effect of S-adenosylmethionine over time on clinical outcome in these patients. It is expected that this agent will slow or halt the progression of this disease.
| Condition | Intervention | Phase |
|
Hepatitis |
Drug: S-adenosylmethionine |
Phase III |
| MedlinePlus related topics: | Hepatitis |
| ChemIDplus related topics: | S-Adenosylmethionine |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study |
| Official Title: | S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contacts and Locations More Information
| Study ID Numbers: | CLIN-014-03S |
| First Received: | April 15, 2005 |
| Last Updated: | May 15, 2007 |
| ClinicalTrials.gov Identifier: | NCT00108589 |
| Health Authority: | United States: Federal Government |
|
|
|
